Avanteca Partners

Type of investor
VC
Based in
Basel
Number of investments
3-5
Industry
biotech, ICT, medtech

Visit website of
Avanteca Partners

Related News

01.11.2023 17:00

Onena Medicines closes 3.7M CHF funding round to advance its novel antibody portfolio

Financing

08.03.2023 17:15

Bearmind raises CHF 1.3M to thrive

Financing

07.06.2022 16:24

Invasight closes CHF 4.5 million seed round to fight invasive cancers

Financing

30.04.2021 15:23

Oncobit secures CHF 2.3 million seed financing round

Financing

Name
Avanteca Partners

Principal

Innosuisse

Swiss Venture Capital Report

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.

Register for more services

Partners

Gebert Rüf Stiftung

Swiss Entrepreneurs Foundation

UBS

Contributors

EPFL Innovation Park Foundation

IFJ

Innovaud

Kendris

Lichtsteiner Foundation

SICTIC

Startup Campus

Swiss Economic Forum

Swisscom

Swissnex

Switzerland Innovation

venturelab

W.A. De Vigier Stiftung

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

ESA BIC Switzerland

StartAngels Network

Switzerland Global Enterprise

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

EPFL Innovation Park Foundation

ESA BIC Switzerland

Gebert Rüf Stiftung

StartAngels Network

Swiss Entrepreneurs Foundation

Switzerland Global Enterprise

Switzerland Innovation

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

W.A. De Vigier Stiftung

By continuing to use this website you agree with our TERMS AND CONDITIONS